Nootropics

SCIENTIFIC STUDIES

1. 2-Methyl-3-Phenylaminomethylquinolin-4-One As Potential Antidepressant With Nootropic Properties
2. A Brief Introduction Of Docosahexaenoic Acid And Its Nootropic Effect [J]
3. A Carbon-13 Nmr Spin-Lattice Relaxation Study Of The Molecular Conformation Of The Nootropic Drug 2-Oxopyrrolidin-1-Ylacetamide
4. A Clinical And Neurophysiological Trial On Nootropic Drugs In Patients With Mental Decline.
5. A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
6. A Comparative Analysis Of The Effect Of Nootropic Preparations With Different Chemical Structures On The Failure Of The Escape Reaction In Rats
7. A Comparative Study Of The Nootropic Properties Of Piracetam And Oxiracetam
8. A Natural And Broad Spectrum Nootropic Substance For Treatment Of Sdat–The Ginkgo Biloba Extract.
9. A New Method For Testing The Psychopharmacologic Pupil Oscillation Hypothesis Following Administration Of A Nootropic Substance
10. A New Nootropic Aniracetam: Its Prevention Of Scopolamine-Induced Retrograde Amnesia And Its Possible Action Mechanisms
11. A New Substance With Nootropic Activity–N-5 (Hydroxynicotinoyl)-L-Glutamic Acid
12. A Nootropic Adrenocorticotropin Analog 4-10-Semax (L5 Years Experience In Its Design And Study)
13. A Novel Effect Of Bifemelane, A Nootropic Drug, On Intracellular Ca2+ Levels In Rat Cerebral Astrocytes
14. A Practical Synthesis Of The Chinese” Nootropic ” Agent Huperzine A: A Possible Lead In The Treatment Of Alzheimer’S Disease
15. A Simplified Route To A Key Intermediate In The Synthesis Of The Chinese Nootropic Agent Huperzine A
16. A Study Of Nootropic Drugs For Anti-Anxiety Action.
17. A Study On Nootropic Activity Of Methanolic Extract Of Brassica Oleraceae Var. Caulorapa Bulb In Rodents
18. A Study To Evaluate The Effect Of Nootropic Drug—Piracetam On Dna Damage In Leukocytes And Macrophages
19. A Traditional Approach To Herbal Nootropic Agents: An Overview
20. A Weird Concept With Unusual Fate: Nootropic Drug
21. Acetylcholinesterase Inhibition In Cognition-Relevant Brain Areas Of Mice Treated With A Nootropic Amazonian Herbal (Marapuama)
22. Acetylcholinesterase Inhibitory Activity Of Thai Traditional Nootropic Remedy And Its Herbal Ingredients.
23. Action Mechanism Study Of The Nootropic Peptide Semax For The Development Of New Therapeutic Solutions
24. Action Of Nootropic Drugs On Transcallosal Responses In Rats
25. Activity Guided Synthesis And Sar Study Of Flavonols As Nootropic Agents
26. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Carum Carvi Linn.(Caraway) Fruit: An Experimental Study In Wistar Rats
27. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Vitis Vinifera (Grape Seed): An Experimental Study In Rat Model
28. Adaptogenic And Nootropic Activities Of Aqueous Extracts Of Carum Carvi Linn (Caraway) Fruit: An Experimental Study In Wistar Rats
29. Adaptogenic And Nootropic Activity Of Mimosa Pudica In Albino Wistar Rats
30. Age-Related Changes Of Cyclic Amp Phosphodiesterase Activity In Rat Brain Regions And A New Phosphodiesterase Inhibitor–Nootropic Agent Adafenoxate.
31. Age-Related Changes Of The Effects Of A Group Of Nootropic Drugs On The Content Of Rat Brain Biogenic Monoamines.
32. Age-Related Differences In Memory And In The Memory Effects Of Nootropic Drugs.
33. Agonist-And Subunit-Dependent Potentiation Of Glutamate Receptors By A Nootropic Drug Aniracetam
34. Allosteric Potentiation Of Quisqualate Receptors By A Nootropic Drug Aniracetam.
35. Along-Term-Potentiation-Like’Facilitation Of Hippocampal Synaptic Transmission Induced By The Nootropic Nefiracetam
36. Ameliorative Influence Of A Nootropic Drug On Motor Activity Of Rats After Bilateral Carotid Artery Occlusion
37. Amino-Acid Composition And Nootropic Properties Of Polynoophyt
38. Amycenone, A Nootropic Found In Hericium Erinaceum
39. An Appraisal Of Medhya Rasayana (Nootropic Herbs) In Present Scenario
40. An Egg Yolk’S Phospholipid-Pennyroyal Nootropic Nanoformulation Modulates Monoamino Oxidase-A (Mao-A) Activity In Sh-Sy5Y Neuronal Model
41. An Experimental Study Of Ethanolic Seed Extract Of Vigna Mungo Linn. For Nootropic Activity On Albino Rats
42. Analysis Of Nootropic Used In Our Hospital During 2008-2010
43. Analysis Of Pharmaceutical Market Of Nootropic Drugs In Ukraine
44. Analytic Evaluation Of Potential Nootropic Agents
45. Analyzing Nootropic Effect Of Phyllanthus Reticulatus Poir. On Cognitive Functions, Brain Antioxidant Enzymes And Acetylcholinesterase Activity Against …
46. Antagonism Of Zn2+ On Nootropic Action Of Piracetam In Mice
47. Anticonvulsant And Neuroprotective Effects Of The Novel Nootropic Agent Nefiracetam On Kainic Acid-Induced Seizures In Rats
48. Anticonvulsant Properties Of The Novel Nootropic Agent Nefiracetam In Seizure Models Of Mice And Rats
49. Antidepressant Activities Of Web 1881, A New Nootropic Agent.
50. Antidepressant, Psychostimulant, And Nootropic Effects Of Major And Trace Element Composition
51. Antiepileptic Effects Of Nootropic Agent, Nefiracetam.-In Vivo Study Of Epileptic Mutant, El Mice.
52. Antihyperglycemic, Antistress And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
53. Antihypoxic Activity Of 2-Methyl-3-Phenylaminomethylquinolin-4 Of The Perspective Antidepressant With Nootropic …
54. Antihypoxic Effect Of 3-Hydroxypyridine And Succinic Acid Derivatives And Their Nootropic Action In Alloxan Diabetes
55. Anti-Inflammatory Properties Of Noopept (Dipeptide Nootropic Agent Gvs-111)
56. Antioxidant Activity And Flavonoid Composition Of The New Nootropic Preparation Polynoophyt
57. Anti-Stress And Nootropic Activity Of Aqueous Extract Of Artocarpus Heterophyllus Fruit, And Y-Maze Test In Rodents.
58. Anti-Stress And Nootropic Activity Of Drugs Affecting The Renin-Angiotensin System In Rats Based On Indirect Biochemical Evidence
59. Anti-Stress Anxiolytic And Nootropic Activity Of Nyctanthes Arbour Tritis Leaves
60. Anti-Stress, Nootropic And Anticonvulsant Potential Of Fruit Extracts Of Piper Longum L
61. Anxiolytic Activity Of Endogenous Nootropic Dipeptide Cycloprolylglycine In Elevated Plus-Maze Test
62. Anxiolytic Activity Of Piracetam, A Nootropic Agent, Following Subchronic Administration In Rodents.
63. Anxiolytic And Nootropic Activity Of Vetiveria Zizanioides Roots In Mice
64. Anxiolytic, Nootropic And Anticonvulsant Activity Of Hemidesmus Indicus In Laboratory Animals.
65. Application Of Nootropic Agents In Complex Treatment Of Patients With Concussion Of The Brain
66. Are Cb1 Receptor Antagonists Nootropic Or Cognitive Impairing Agents?
67. Assessing The Validity Of Danio Rerio As A Model Organism For Nootropic Research: The Effects Of Phenylpiracetam On Larval Zebrafish Behavior
68. Assessment Of Nootropic Activity Of Panchagavya Ghrita In Animal Models
69. Assessment Of Nootropic And Amnestic Activity Of Centrally Acting Agents
70. Assessment Of The Prevalence Of Nootropic Drugs By Elderly Patients In Geriatric Practice
71. Asthenic Syndrome In Clinical Course Of Acute Period Of Brain Concussion During Complex Treatment Using Nootropic Agents
72. Astrocytes Mediated The Nootropic And Neurotrophic Effects Of Sarsasapogenin-Aa13 Via Upregulating Brain-Derived Neurotrophic Factor
73. Avoidance Facilitation In Adult Mice By Prenatal Administration Of The Nootropic Drug Oxiracetam
74. Bacopa Monniera, A Reputed Nootropic Plant: An Overview
75. Bacopa Monnieri, A Nootropic Drug
76. Balance And The Nitric Oxide System In The Brain Tissue Of Rats Subjected To Experimental Acute Impairment Of Cerebral Blood Flow: The Therapeutic Effects Of Nootropic …
77. Bar-Pressing For Water Reward: Effects Of Nootropic Drugs And Peptides On Discrimination Learning In Rats.
78. Behavioral And Biochemical Evidences For Nootropic Activity Of Boldine In Young And Aged Mice
79. Behavioral And Electrophysiological Analysis Of The Choline-Positive Effect Of Nootropic Dipeptide Acylproline (Gvs-111)
80. Behavioral Pharmacological Studies Of Nootropic Candidates On The Central Dopaminergic Activity Rats
81. Beneficial Effect Of Sodium Thiosulfate Extends Beyond Myocardial Tissue In Isoproterenol Model Of Infarction: Implication For Nootropic Effects
82. Bioaccessibility Of The New Dipeptide Nootropic Drug Noopept
83. Biogenic Monoamine Uptake By Rat Brain Synaptosomes During Aging. Effects Of Nootropic Drugs
84. Blockade Of The Nootropic Action Of Piracetam-Like Nootropic s By Adrenalectomy: An Effect Of Dosage?
85. Blood Mononuclear Cells As Speculum Of Emotional Stress Analyzed By Synchrotron Infrared Spectroscopy And A Nootropic Drug
86. Brain Entry And Direct Central Pharmacological Effects Of The Nootropic Drug Oxiracetam
87. Brain Neurotransmitter Receptor Binding And Nootropic Studies On Indian Hypericum Perforatum Linn.
88. Can Nootropic Drugs Be Effective Against The Impact Of Ethanol Teratogenicity On Cognitive Performance?
89. Can The Pattern Of Neuropsychological Improvement Obtained With Cholinergic Drugs Be Used To Infer A Cholinergic Mechanism In Other Nootropic Drugs?
90. Cannabis-Induced Impairment Of Learning And Memory: Effect Of Different Nootropic Drugs
91. Cardiotoxicity Of The Nootropic Supplement, Phenylethylamine
92. Cell Line Toxicity Study And Pharmacological Screening Of Effective Nootropic Herbal Formulation In Rat
93. Central Depressant And Nootropic Effects Of Daytime Melatonin In Mice
94. Changes In Brain Biogenic Monoamines Induced By The Nootropic Drugs Adafenoxate And Meclofenoxate And By Citicholine (Experiments On Rats).
95. Changes In The Indices Of Neuronal Functional Activity Under The Action Of Piracetam As A Possible Basis For Realizing The Effects Of Nootropic Agents
96. Changes In The Narrow-Band Components Of The Eeg Spectrum Under The Action Of Nootropic Drugs
97. Changes Of Dopamine Metabolism By Hypoxia And Effect Of Nootropic Drugs.
98. Changes Of High-Affinity Choline Uptake In The Hippocampus Of Old Rats After Long-Term Administration Of Two Nootropic Drugs (Tacrine And Ginkgo Biloba Extract)
99. Characteristics Of Antiischemic And Nootropic Properties Of Ademol In A Rat Model Of Acute Brain Ischemia
100. Characterization Of The Transcallosal Response In Aged Rats And Its Susceptibility To Nootropic Drugs
101. Chemistry, Pharmacology, And Clinical Efficacy Of The Chinese Nootropic Agent Huperzine A
102. Clinical And Psychometric Evaluation Of The Efficacy Of Nootropic Drugs: Characteristics Of Several Procedures.
103. Cognitive Improvement In Clinical Trials With Nootropic Drugs: When Can It Be Expected And How To Clarify Its Meaning.
104. Cognitive Psychophysiology In Nootropic Drug Research: Effects Of Ginkgo Biloba On Event-Related Potentials (P300) In Age-Associated Memory Impairment
105. Comparative Analysis Of Nootropic Means Of Consumption In Ukraine, Estonia And Norway
106. Comparative Assessment Of Nootropic Activity Of Yashtimadhu Choorna And Yashtimadhu Kshirapaka In Young And Aged Mice
107. Comparative Characteristics Of The Nootropic Action Of Phenibut And Phepyrone.
108. Comparative Efficiency Of Nootropic Drugs In Complex Treatment Of Patients With Remote Consequences Of Closed Craniocereberal Trauma
109. Comparative Experimental Research Into The Nootropic Action Of Procaine And Pyracetam.
110. Comparative Influence Of Nootropic Preparations On The Emetic Effect Of Morphine
111. Comparative Neurophysiological Study Of The Nootropic Drugs Piracetam And Centrophenoxine
112. Comparative Nootropic Effect Of Evolvulus Alsinoides And Convolvulus Pluricaulis
113. Comparative Studies On The Anticonvulsant Effectiveness Of Nootropic Drugs In Kindled Rats.
114. Comparative Studies On The Effects Of The Nootropic Drug Adafenoxate And Of The Cerebral Vasodilator Flunarizine On Arterial Smooth Muscles.
115. Comparative Studies On The Effects Of The Nootropic Drugs Adafenoxate, Meclofenoxate And Piracetam, And Of Citicholine On Scopolamine-Impaired Memory, Exploratory …
116. Comparative Study Of The Neuroprotective And Nootropic Activities Of The Carboxylate And Amide Forms Of The Hldf-6 Peptide In Animal Models Of Alzheimer’S Disease
117. Comparision Of Nootropic Effects Of Kaixinsan Prescription And Kaixinsan Without Poria Cocos (Schw.) Wolf To Alzheimer’S Mice Model
118. Comparison Of 1-(2-Naphthyloxymethylcarbonyl) Pyrrolidine, Pp-20/Dpj, Newly Synthesized Compound With The Nootropic Drug Piracetam In Normal And Aluminum …
119. Comparison Of Nootropic And Neuroprotective Features Of Aryl-Substituted Analogs Of Gamma-Aminobutyric Acid
120. Computational Analysis Of Theacrine, A Purported Nootropic And Energy-Enhancing Nutritional Supplement
121. Conformation Of The Nootropic Agents 1-(4-Methoxybenzoyl)-5-Oxo-2-Pyrrolidinepropanoic Acid (Ci-933) And 4-Hydroxymethyl-1-Benzyl-Pyrrolidin-2-One (Web-1868) …
122. Conformational Transitions In The Nootropic Peptide Semax (Mehfpgp) And Its N-Terminal Modifications
123. Correction To: A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
124. Correction: The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than Classical Cocaine-Like Inhibitors
125. Current Aspects Of The Search Of Effective Nootropic Drugs
126. Cyclic Gmp Mimicks Potentiation Effect Of The Nootropic Agent Vinpocetine On The High Threshold A-Current In The Mollusk Neurons
127. Delayed Nootropic Effects Of Arginine Vasopressin After Early Postnatal Chronic Administration To Albino Rat Pups
128. Design And Study Of Some Novel Ibuprofen Derivatives With Potential Nootropic And Neuroprotective Properties
129. Design, Synthesis And Nootropic Activity Of New Analogues Of Sunifiram And Sapunifiram, Two Potent Cognition-Enhancers
130. Design, Synthesis, And Preliminary Pharmacological Evaluation Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones As A New Class Of Highly Potent Nootropic Agents
131. Designing A Formulation Of The Nootropic Drug Aniracetam Using 2-Hydroxypropyl-Β-Cyclodextrin Suitable For Parenteral Administration
132. Designing Nootropic Dipeptides Using An Evolutionary-Genetic Approach
133. Detection Of Nootropic Activity Indicated By Acute Inhibition Of Orientation Reaction
134. Development And Pharmacology Of Nootropic And Antidepressive Preparations Based On Eaa Receptor Ligands
135. Development Of New Drugs Of Plant Origin With Nootropic Action
136. Development Of New Drugs Of Plant Origin With Nootropic Action
137. Developmental Dyslexia And The Nootropic Concept
138. Different Susceptibilities Of Long-Term Potentiations In Ca3 And Ca1 Regions Of Guinea Pig Hippocampal Slices To Nootropic Drugs
139. Dipeptide Nootropic Agent Gvs-111 Prevents Accumulation Of The Lipid Peroxidation Products During Immobilization
140. Discussion On Tcm Mechanism Of Nootropic And Brain-Invigorating Chinese Traditional And Herbal Prescriptions And Drugs.
141. Disposition Of Ethimizol, A Nootropic Drug, In Rats And Mice.
142. Disposition Of Ethimizol, A Xanthine-Related Nootropic Drug, In Perfused Rat Liver And Isolated Hepatocytes.
143. Dissociation Of The Anti-Amnesic And Antihypoxic Effects Of Nootropic And Antihypoxic Preparations
144. Dm235 (Sunifiram): A Novel Nootropic With Potential As A Cognitive Enhancer
145. Dose-Dependent Pharmacokinetics Of A Xanthine-Related Nootropic Drug, Ethimizol, In Rats
146. Effect Of A New Nootropic Agent, Cgs 5649B, On Cognition, Function, And Behavior In Dementia
147. Effect Of Anti-Epileptic, Nootropic Drugs On The Expression Of Erk2 And Ncam1 In The Hippocampus Changes On The Epileptic Rats With Cognitive Dysfunction
148. Effect Of Donepezil In Patients With Alzheimer’S Disease Previously Untreated Or Treated With Memantine Or Nootropic Agents In Germany: An Observational Study
149. Effect Of Drugs Of The Nootropic Class On Rat Behavior After Deprivation Of The Paradoxical Stage Of Sleep
150. Effect Of Idebenone And Various Nootropic Drugs On Lipid Peroxidation In Rat Brain Homogenate In The Presence Of Succinate
151. Effect Of Modification Of The N-Terminal Region Of Semax On The Expression Of Nootropic Effect Of Semax Analogs
152. Effect Of Natural Nootropic And Adaptogen Preparations On The Cortex Bioelectrical Activity In Rats
153. Effect Of Nootropic Agents On Impulse Activity Of Cerebral Cortex Neurons
154. Effect Of Nootropic Agents On Serum Biochemical Indices In Intellectually Deficient Children
155. Effect Of Nootropic Agents On The Brain Bioelectrical Activity And On The Indices Of Neuromediator Metabolism In The Acute Period Of Severe Craniocerebral Trauma
156. Effect Of Nootropic Agents On The Lowering Of The Spasm Threshold After A Single Ethanol Application
157. Effect Of Nootropic And Psycho-Stimulants On Children With Infantile Brain Damages.
158. Effect Of Nootropic Drugs On Age‐Dependent Changes In Transmitter Release
159. Effect Of Nootropic Drugs On Normal And Disturbed Sleep Of The Elderly: Controlled Studies With Pyridoxilate And Street Noise
160. Effect Of Nootropic Drugs On Restitution Of Biochemical Changes In Cns Tissue After Paradoxical Sleep Deprivation In Rats.
161. Effect Of Nootropic Drugs On The Dopamine Release And Dopamine Uptake In Structures Of The Rat Striatum
162. Effect Of Nootropic Solcoseryl® On Kainic Acid-Induced Excitotoxic Brain Injury
163. Effect Of Piper Longum On Urinary Metabolites And Its Correlation With Nootropic Activity In Rat Models
164. Effect Of Piracetam, A Nootropic Agent, On Discrimination Learning Deficits Induced By Parental Undernutrition And Environmental Impoverishment In Young Rats.
165. Effect Of Piracetam, A Nootropic Agent, On Experimental Gastric Ulcers In Rat.
166. Effect Of Repeated Application Of Nootropic Drugs On Sleep In Rats.
167. Effect Of Scopolamine And Nootropic Drugs On Rewarded Alternation In A T-Maze
168. Effect Of The Combination Of The Benzodiazepine Tranquilizer Medazepam And The Nootropic Agent Meclofenoxate On The Activity Of Rat Brain Muscarinic Receptors
169. Effect Of The Nootropic Agent Cerebrolysin In Cerebral Ischemia In Rats With Varying Behavioral Reactions In The Open Field Test
170. Effect Of The Nootropic Drug Oxiracetam On Field Potentials Of Rat Hippocampal Slices.
171. Effect Of The Novel Dipeptide Nootropic Agent Noopept And Its Metabolite Cyclo-L-Prolylglycine On The Transcallosal Evoked Potential In The Rat Brain
172. Effect Of The Novel Nootropic And Neuroprotective Dipeptide Noopept On The Streptozotocin-Induced Model Of Sporadic Alzheimer Disease In Rats
173. Effectiveness Of Nootropic Drugs With Cholinergic Activity In Treatment Of Cognitive Deficit: A Review
174. Effects Of A Cholinergic Nootropic (Web 1881 Fu) On Event-Related Potentials Recorded In Incidental And Intentional Memory Tasks
175. Effects Of Aniracetam, A Nootropic Drug, In Senile Dementia
176. Effects Of Heptapeptide Of The Tuftsin Group With Nootropic Components Of Action And Piracetam On Formation Of Escape Reaction In Normal Conditions And In Conflict …
177. Effects Of Nebracetam (Web 1881 Fu), A Novel Nootropic , As A M1-Muscarinic Agonist
178. Effects Of Nefiracetam, A Novel Pyrrolidone‐Type Nootropic Agent, On The Amygdala‐Kindled Seizures In Rats
179. Effects Of Nicotinic Cholinoreceptor Ligands And Nootropic Drugs On The Spontaneous Exploratory Activity In A Labyrinth In Mice
180. Effects Of Nootropic Agents On The Performing Of Active Two-Way Avoidance Tasks In Young And Old Rats.
181. Effects Of Nootropic Agents On Visual Functions And Lacrimal Antioxidative Activity In Patients With Primary Open-Angle Glaucoma
182. Effects Of Nootropic Drugs For Demented Patients—A Study Using Loreta
183. Effects Of Nootropic Drugs In A Scopolamine-Induced Amnesia Model In Mice
184. Effects Of Nootropic Drugs On Behavior Of Balb/C And C57Bl/6 Mice In The Exploratory Cross-Maze Test
185. Effects Of Nootropic Drugs On Brain Cholinergic And Dopaminergic Transmission.
186. Effects Of Nootropic Drugs On Dopaminergic Systems In The Cns.
187. Effects Of Nootropic Drugs On Hippocampal And Cortical Bdnf Levels In Mice With Different Exploratory Behavior Efficacy
188. Effects Of Nootropic Drugs On Some Behavioural And Biochemical Changes After Early Postnatal Hypoxia In The Rat.
189. Effects Of Nootropic Drugs On The Sleep-Waking Pattern Of The Rat.
190. Effects Of Red Ginseng Saponins And Nootropic Drugs On Impaired Acquisition Of Ethanol-Treated Rats In Passive Avoidance Performance
191. Effects Of The Nootropic Agents Adafenoxate And Meclofenoxate On Brain Biogenic Monoamines In Aged Rats.
192. Effects Of The Nootropic Agents Adafenoxate, Meclofenoxate And The Acetylcholine Precursor Citicholine On The Brain Muscarinic Receptors (Experiments On Rats).
193. Effects Of The Nootropic Awd 52-39 On The Blood-Brain Transfer Of Leucine, Choline And Glucose In Rats After 14-D Exposure To Ethanol.
194. Effects Of The Nootropic Drug Nefiracetam On The Gabaa Receptor-Channel Complex In Dorsal Root Ganglion Neurons
195. Effects Of The Nootropic Nefiracetam On Rat Hippocampal Gaba Release
196. Effects Of Various Nootropic Candidates On The Impaired Acquisition Of Ethanol-Treated Rats In Step-Through Test
197. Effects Of Web 1881 Fu, A Novel Nootropic , On Cholinergic And Adrenergic Receptors In The Rat Brain: Action On M1-Muscarinic Receptors
198. Efficacy Of A Nootropic Spearmint Extract On Reactive Agility: A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial
199. Efficacy Of The Peptidergic Nootropic Drug Cerebrolysin In Patients With Senile Dementia Of The Alzheimer Type (Sdat)
200. Electrographic Correlates Of The Antiamnestic Action Of Nootropic Agents Following Deprivation Of The Paradoxical Sleep Phase
201. Electrophysiological Correlates Of Efficacy Of Nootropic Drugs In The Treatment Of Consequences Of Traumatic Brain Injury In Adolescents
202. Electrophysiological Evaluation Of The Demented State And The Nootropic Effect Of Ta-0910 By” Automated Fluctuation Analysis” Of The High-Frequency Eeg–Relation …
203. Endolumbal Nootropic -Ozone Therapy In Complex Treatment Of Patients With Complicated Spinal Injury In Acute Period
204. Endolumbar Nootropic -Ozone Therapy In Multimodality Treatment Of Patients With A Complicated Spinal Injury At Its Acute Period
205. Enhancement Of Adenosine‐Induced Relaxant Responses Of The Guinea‐Pig Isolated Taenia Coli And Aortae By A Novel Nootropic Agent By‐1949: Comparison With …
206. Enhancement Of Neuronal Calcium Channel Currents By The Nootropic Agent, Nefiracetam (Dm-9384), In Ng108-15 Cells
207. Enhancement Of Nootropic Effect Of Duloxetine And Bupropion By Caffeine In Mice
208. Establishing Natural Nootropic s: Recent Molecular Enhancement Influenced By Natural Nootropic
209. Estimation Of Being And Perspective Of Demand On Nootropic Drugs
210. Estimation Of The Antioxidant Effect Of The Nootropic Dipeptide Noopept On The Model Of Fe2+-Induced Chemiluminescence Of Lipoproteins Of Human Serum In Vitro
211. Ethical Underpinning And Implications Of “Nootropic ” Concept
212. Ethylene Bis-Imidazoles Are Highly Potent And Selective Activators For Isozymes Va And Vii Of Carbonic Anhydrase, With A Potential Nootropic Effect
213. Evaluation Of Antibacterial, Antioxidant And Nootropic Activities Of Tiliacora Racemosa Colebr. Leaves: In Vitro And In Vivo Approach
214. Evaluation Of Anticonvulsant And Nootropic Effect Of Ondansetron In Mice
215. Evaluation Of Geriatric Patients With Special Reference To Clinical Trials Of Socalled Nootropic Drugs
216. Evaluation Of Green Tea For Its Nootropic Activity
217. Evaluation Of Nootropic Activity Of Aegle Marmelos Extract Using Different Experimental Models In Rats
218. Evaluation Of Nootropic Activity Of Carica Papaya In Mice
219. Evaluation Of Nootropic Activity Of Cressa Cretica In Scopolamine-Induced Memory Impairment In Mice
220. Evaluation Of Nootropic Activity Of Curcuma Longa Leaves In Diazepam And Scopolamine-Induced Amnesic Mice And Rats
221. Evaluation Of Nootropic Activity Of Ethanolic And Aqueous Root Extracts Of Adhatoda Vasica Nees In Rodents
222. Evaluation Of Nootropic Activity Of Ethanolic Extract Of Ardisia Blatteri Using Different Experimental Models In Rats
223. Evaluation Of Nootropic Activity Of Limonia Acidissima Against Scopolamine-Induced Amnesia On Rats
224. Evaluation Of Nootropic Activity Of Salvia Officinalis L. Extract Using Different Experimental Models In Rats. J
225. Evaluation Of Nootropic Activity Of Sida Cordifolia In Mice
226. Evaluation Of Nootropic Activity Of Slimaluma, An Enriched Phytochemical Composition Of Caralluma Fimbriata In Mice
227. Evaluation Of Nootropic Activity Of Smrithi: A Polyherbal Formulation
228. Evaluation Of Nootropic Activity Of Two Marketed Drugs Of Bacopa Monnieri In Scopolamine Induced Amnesic Models
229. Evaluation Of Nootropic Activity Of Vigna Mungo Linn. On Scopolamine Induced Cognitive Dysfunction In Mice
230. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
231. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
232. Evaluation Of Nootropic And Neuroprotective Effects Of Low Dose Aspirin In Rats
233. Evaluation Of Nootropic Drugs Using Event-Related Potential (P300) In Monkeys
234. Evaluation Of Nootropic Effect Of Argyreia Speciosa In Mice
235. Evaluation Of Nootropic Effects Of Aqueous Extract Of Tridax Procumbens Linn On Cognitive Functions In Mice
236. Evaluation Of Nootropic Effects Of Galantamine And Sildenafil As A Combination In Mice
237. Evaluation Of Nootropic Potential Of Green Peas In Mice
238. Evaluation Of Nootropic Potential Of Ocimum Sanctum Linn. In Mice
239. Evaluation Of Polyherbal Preparation Divya Medha Vati For Nootropic , Anxiolytic And Anticholinesterase Activity
240. Evaluation Of The Anti-Amyloidogenic Potential Of Nootropic Herbal Extracts In Vitro
241. Evaluation Of The Nootropic Activity Of Arabica Coffee Pulp Extract (Coffea Arabica)
242. Evaluation Of The Nootropic Effect Of Mebikar In Clinical Practice
243. Evalution Of Nootropic And Anti-Nociceptive Activity Of Green Tea In Comparison With Medha Rasayana
244. Evidence Based Anti-Dementing Activity Of Saraswata Ghrita” A Nootropic Compound From Ayurveda
245. Evidence For Nootropic Effect Of Br-16A (Mentat [R]), A Herbal Psychotropic Preparation, In Mice
246. Evidence Pharmacy: Inclusion To The Schemes Of Pharmacotherapy Of The Drug Addicted Patients With Opioid Dependence Of The Nootropic Drugs
247. Examination Of Lesions In The Urinary Bladder And Kidney Of Dogs Induced By Nefiracetam, A New Nootropic Agent
248. Examining The Nootropic Effects Of A Special Extract Of Bacopa Monniera On Human Cognitive Functioning: 90 Day Double‐Blind Placebo‐Controlled Randomized Trial
249. Excitatory Amino Acids And Neuronal Plasticity: Modulation Of Ampa Receptors As A Novel Substrate For The Action Of Nootropic Drugs.
250. Experience In The Application Of Pramistar, A New Nootropic Preparation, In The Treatment Of Memory Disorders In Patients With Cerebrovascular Pathology
251. Experimental And Clinical Evaluation Of Nootropic Activity Of Bacopa Monniera Linn.(Brahmi)
252. Experimental Studies On The Effects Of Nootropic Mixture (Yizhiheji) In Improving Studying & Memorizing And Fighting Aging Of Alzheimer Diseased Rats
253. Exploring The Nootropic Effect Of Juniperus Recurva Extract: Possible Involvement Of Acetylcholinesterase Inhibition
254. Facilitation Of Evoked Transcallosal Responses By Nootropic Agents
255. Factors Influencing The Prescribing Of Nootropic Drugs. Results Of A Representative Inquiry In Lower Saxony
256. Fast And” Slow” Components Of Psychotropic Activity Of The Drugs With Nootropic Effects
257. Fast Thin-Layer Densitometric Determination Of The Nootropic Piracetam In Biological Material
258. Formulation And Standardization Of Medhya Rasayana–A Novel Ayurvedic Compound Nootropic Drug
259. Gamma-Aminobutyric Acid Metabolism In The Rat Brain After Administration Of Nootropic Agents
260. Geriatric Pharmacology. Pharmacokinetics And Pharmacodynamics In The Elderly. Problems With Geriatric And Nootropic Drugs
261. Ginkgo Biloba Is Not A Smart Drug: An Updated Systematic Review Of Randomised Clinical Trials Testing The Nootropic Effects Of G. Biloba Extracts In Healthy People
262. Global Dimensional Complexity Of Multi-Channel Eeg Indicates Change Of Human Brain Functional State After A Single Dose Of A Nootropic Drug
263. Hedychium Spicatum: Evaluation Of Its Nootropic Effect In Mice
264. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice
265. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice.
266. Herbal Nootropic Agents.
267. High Field Nmr Techniques And Molecular Modelling Study Of The Inclusion Complexes Of The Nootropic Drug Tenilsetam (Cas-997) In Cyclodextrins
268. High-Performance Liquid Chromatographic Determination Of A New Nootropic , N-(2, 6-Dimethylphenyl)-2-(2-Oxo-1-Pyrrolidinyl) Acetamide, In Human Serum And Urine
269. How Can You Avoid Inferior Nootropic Supplements
270. Hunter Focus Review–Is It Really The Best Nootropic Stack?
271. Huperzine A, A Nootropic Agent, Inhibits Fast Transient Potassium Current In Rat Dissociated Hippocampal Neurons
272. Huperzine A, A Nootropic Alkaloid, Inhibits N-Methyl-D-Aspartate-Induced Current In Rat Dissociated Hippocampal Neurons
273. Hypericum Perforatum As A Nootropic Drug: Enhancement Of Retrieval Memory Of A Passive Avoidance Conditioning Paradigm In Mice
274. Hypoglycemic, Antistress, Anxiolytic, And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
275. Hypoxia And Memory. Specific Features Of Nootropic Agents Effects And Their Use
276. I15 Nootropic Effect And Action Mechanisms Of Ginsenoside Rg1, A Smart Drug Candidate
277. Identification And Evaluation Of A Panel Of Ginsenosides From Different Red Ginseng Extracts With Nootropic Effect
278. Identifying Nootropic Drug Targets Via Large-Scale Cognitive Gwas And Transcriptomics
279. Immunostimulant, Cerebroprotective & Nootropic Activities Of Andrographis Paniculata Leaves Extract In Normal & Type 2 Diabetic Rats
280. Impact Of A Purported Nootropic Supplementation On Measures Of Mood, Stress, And Marksmanship Performance In Us Active Duty Soldiers
281. Impact Of Nootropic Supplementation On Measures Of Marksmanship Performance In Active Duty Soldiers
282. Impaired Plasticity Of Hippocampal Synaptic Transmission In Rats Exposed To Prenatal Hypoxia Is Normalized By Treatment With Nootropic Dipeptides
283. Impairment Of Contextual Fear Conditioning In Rats By Group I Mglurs: Reversal By The Nootropic Nefiracetam
284. Impairment Of Learning And Memory In Rats Neonatally Injected With 6-Hydroxydopamine (6-Ohda). Effects Of Nootropic Drugs
285. Impairment Of Learning And Memory In Shuttle Box-Trained Rats Neonatally Injected With 6-Hydroxydopamine. Effects Of Nootropic Drugs.
286. Improvement Of Avoidance Acquisition By The Nootropic Drug Oxiracetam In Mice.
287. Improving Mental Performance In An Athletic Population With The Use Of Ārepa®, A Blackcurrant Based Nootropic Drink: A Randomized Control Trial
288. In Silico And In Vitro Evaluation Of Brain Penetration Properties Of Selected Nootropic Agents
289. In Silico Target Identification Of Nootropic Bioactive Compounds From Ayurvedic Herbs
290. In Vitro And In Vivo Effect Of The Nootropic Agent Adafenoxate On The 5-Ht1 Sites In Different Rat Brain Structures
291. Influence Of Antiarrhythmic And Nootropic Drugs On Model And Biological Membranes
292. Influence Of Nootropic And Antidepressive Drugs On Open Field And Running Wheel Behavior In Spontaneously High And Low Active Mice
293. Influence Of Nootropic Drugs On Apomorphine-Induced Stereotyped Behaviour In Rats.
294. Influence Of Nootropic Drugs On Drinking Behaviour In Ethanol-Preferring Mice And Ethanol-Induced Increase Of Seizure Susceptibility.
295. Influence Of Nootropic Drugs On The Age-Dependent Potassium-Coupling Of Transmitter Release.
296. Influence Of Nootropic Drugs On The Learning-And Memory-Impairing Effect Of Diethyldithiocarbamate In Albino Rats.
297. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Clonidine In Albino Rats.
298. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Diethyldithiocarbamate And Clonidine In” Step Down” Passive Avoidance In Albino Rats.
299. Influence Of Nootropic Drugs On The Stimulus‐Release Relationship Of Dopaminergic Structures
300. Influence Of Ring Size On The Cognition-Enhancing Activity Of Dm235 And Mn19, Two Potent Nootropic Drugs
301. Influence On Memory By A New Nootropic Compound
302. Investigation Of Nootropic Drugs (Pyramem And Orocetam) For Their Teratogenic Effect
303. Investigation Of The Effects Of Hydration And Amphiphilic Properties Of Nootropic Drugs Of Piracetam And Pramiracetam
304. Investigations On The Binding Properties Of The Nootropic Agent Pyroglutamic Acid.
305. Involvement Of Gaba In Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
306. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drugâ Piracetam
307. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drug—Piracetam
308. Isolation, Identification, And Nootropic Activity Of Compounds In Alfredia Cernua Chloroform Extract
309. Just Say “Nootropic ”: The Effects Of Nicotine On Memory And Learning
310. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets
311. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets.
312. Late Consequences Of Neonatal Short-Term Inhibition Of Protein Synthesis In Adult Rats And The Effects Of Nootropic Drugs: A Biochemical And Behavioural Study.
313. Learning And Memory Impairment In Albino Rats After Potassium Ethylxanthogenate. Effects Of Nootropic Agents.
314. Literature Review: Caffeine As Mental Stimulant And Nootropic
315. Ltp Deficiency In Adult Rats Prenatally Exposed To Ethanol Or Hypoxia And Its Correction By Postnatal Treatment With Nootropic Compounds
316. Mechanism Of Action Of Tetrahydro-N, N-Dimethyl-5, 5-Diphenyl-3-Furanemethanamine, A Putative Nootropic , Anti-Epileptic And Antidepressant Compound
317. Mechanism Of Nootropic Digam Action In Hypofunction Of Brain Dopaminergic System
318. Memory Effects Of A Group Of Newly-Synthesized Pyrrolidine Derivatives With Putative Nootropic Effect.
319. Memory Effects Of The Combination Of Medazepam With Nootropic Agents.
320. Memory Impairment Induced By Combined Disturbance Of Noradrenergic And Dopaminergic Neurotransmissions: Effects Of Nootropic Drugs.
321. Memory Retrieval Deficits: Alleviation By Etiracetam, A Nootropic Drug
322. Mental Retardation Among Children With Cerebral Palsy As Observed In Nepal With A Small Trial With Nootropic (Modafinil)
323. Meta-Analysis: The Efficacy Of Nootropic Agent Cerebrolysin In The Treatment Of Alzheimer’S Disease
324. Methodological Approach To The Clinical Evaluation Of Nootropic Drugs
325. Methodological Approaches To The Design Of Solid Dosage Forms Of Nootropic Action On The Basis Of Plant Raw Materials
326. Methylazoxymethanol Microencephaly In Rats: Neurochemical Characterization And Behavioral Studies With The Nootropic Oxiracetam.
327. Mind Lab Pro Review: Should You Buy This Nootropic ?%% Sep%%%% Sitename%%
328. Modern Approach To Development Of Nootropic Agents Based On Γ-Aminobutyric Acid
329. Modern Problems Of The Pharmacology Of Nootropic Agents: The Status And Outlook
330. Modulating Effect Of The Nootropic Drug, Piracetam On Stress‐And Subsequent Morphine‐Induced Prolactin Secretion In Male Rats
331. Modulation Of Ampa Receptor Desensitization By Nootropic Drugs And Endogenous Proteins
332. Modulation Of Long-Term Memory By Delayed Administration Of The Amide Of L-Pyroglutamyl-D-Alanine, A Nootropic Agent, In Spaced And Massed Training In Rats
333. Modulation Of The Effects On Learning And Memory Of Nootropic Drugs And Central Stimulants When Applied Together.
334. Modulation Of The Long-Term Memory By Delayed Administration Of The Nootropic Agent L-Pyroglutamyl-D-Alaninamide During Spaced And Massed Training Of Rats
335. Modulation Of The Neuronal Nicotinic Acetylcholine Receptor-Channel By The Nootropic Drug Nefiracetam
336. Molecular Determinants For Drug-Receptor Interactions: 1. Solid-State Structure And Conformation Of The Novel Nootropic Agent 2-Pyrrolidone-N-Acetamide: X-Ray …
337. Molecular Determinants For Drug—Receptor Interactions: Part 2. An Ab Initio Molecular Orbital And Dipole Moment Study Of The Novel Nootropic Agent Piracetam (2 …
338. Molecular Docking, Spectroscopic Studies And Quantum Calculations On Nootropic Drug
339. Molecular Modeling Of Β‐Cyclodextrin Complexes With Nootropic Drugs
340. Molecular Simplification Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones Gives Piperazine Derivatives That Maintain High Nootropic Activity
341. Molecular-Biochemical Mechanisms Of The Effects Of Nootropic Agents
342. Monitoring The Internet For Nootropic Substances Available To Australian Consumers
343. Moringa Oleifera Supplemented Diet Modulates Nootropic -Related Biomolecules In The Brain Of Stz-Induced Diabetic Rats Treated With Acarbose
344. Multiple Mechanisms Underlying Nootropic Drug-Induced Enhancement Of Neuronal Responses Mediated By Activation Of Glutamate Nmda-Type Receptors
345. Naftidrofuryl Oxalate, Nootropic Effects On The Scopolamine-And The Basal Forebrain Lesion-Induced Amnesia In Rats
346. Natural Product Synthesis Via Cyclobutanes: Part I, Asymmetric Synthesis Of (+)-Byssochlamic Acid, Part Ii, An Approach To The Nootropic Agent Huperzine A
347. Negative Regulation Of Opioid Receptor‐G Protein‐Ca2+ Channel Pathway By The Nootropic Nefiracetam
348. Nerve Growth Factor And Nootropic Drug Cerebrolysin But Not Fibroblast Growth Factor Can Reduce Spatial Memory Impairment Elicited By Fimbria-Fornix Transection: Short …
349. Neurochemical Assessments Of The Actions Of Novel Agents Having Nootropic And Anxiolytic Potential: The Measurement In Brain …
350. Neurocognitive Effect Of Nootropic Drug Brahmi (Bacopa Monnieri) In Alzheimer’S Disease
351. Neurogenix-Fast Acting Liquid Nootropic
352. Neuronal Ca2+ Channels And Nicotinic Ach Receptors As Functional Targets Of The Nootropic Nefiracetam
353. Neuropathobiology Of Senile Dementia And Mechanism Of Action Of Nootropic Drugs
354. Neuropharmacological Review Of The Nootropic Herb Bacopa Monnieri
355. Neurophysiological Analysis Of The Correction By Nootropic Substances Of Disorders In The Bioelectric Activity Of The Brain In Animals During Chronic Administration Of …
356. Neurophysiological Analysis Of The Effects Of Nooglutil As Opposed To Known Nootropic Drugs
357. Neuroprotective And Nootropic Actions Of A Novel Cyclized Dipeptide After Controlled Cortical Impact Injury In Mice
358. Neuroprotective And Nootropic Activity Of Carica Papaya Seeds On Diabetes Induced Cognitive Decline In Rats
359. Neuroprotective And Nootropic Activity Of Clitorea Ternatea Linn.(Fabaceae) Leaves On Diabetes Induced Cognitive Decline In Experimental Animals
360. Neuroprotective And Nootropic Drug Noopept Rescues Α-Synuclein Amyloid Cytotoxicity
361. Neuroprotective Effect Of Kapakh, Representative Of New Nootropic Class Non-Anticholinesterase Organophosphoric Compounds
362. Neuroprotective Properties Of Nootropic Dipeptide Gvs-111 In In Vitro Oxygen-Glucose Deprivation, Glutamate Toxicity And Oxidative Stress
363. Neuropsychopharmacological Effects Of The Ayurvedic Nootropic Bacopa Monniera Linn.(Brahmi)
364. New (−)− Cytisine Derivatives With Nootropic Activity
365. New Aspects Of The Neurophysiological Mechanism Of The Action Of Nootropic Preparations
366. New Nootropic Preparation From Blood Plasma (Adement): Lack Of Therapeutic Influence On Drosophila Neurodegenerative Model
367. New Pharmacological Perspectives On Nootropic Drugs
368. New Trends In The Search For Nootropic Preparations
369. Nmda Component In The Effects Of Piracetam And New Nootropic Peptide Gvs-111 On The Neocortical And Hippocampal Eeg In Conscious Rats
370. Nmda-Independent Long-Term Depression Of Synaptic Transmission In The Hippocampus: Mechanisms Of Induction And Effects Of Nootropic Drugs
371. Non-Linear Dose Effect Relationship In Anxiolytic And Nootropic Activity Of Lithium Carbonate And Nardostachys Jatamansi In Rats
372. Nonopioid And Neuropathy-Specific Analgesic Action Of The Nootropic Drug Nefiracetam In Mice
373. Noocube Review⋆ Nootropic Supplement⋆ Does It Work?
374. Nootropic (Medhya) Effect Of Bhāvita Śaṇkhapuṣpī Tablets: A Clinical Appraisal
375. Nootropic Action Of Proline-Based Topological Analogs Of Piracetam
376. Nootropic Action Of Some Antihypertensive Drugs: Computer Predicting And Experimental Testing
377. Nootropic Activity Of A Novel (-)-Cytisine Derivative (3Ar, 4S, 8S, 12R, 12As, 12Br)-10-Methyl-2-Phenyloctahydro-1H-4, 12A-Etheno-8, 12-Methanopyrrolo [3′, 4′: 3, 4] …
378. Nootropic Activity Of Acetaminophen Against Colchicine Induced Cognitive Impairment In Rats
379. Nootropic Activity Of Ajuga Bracteosa Wall On Scopolamine Induced Memory Deficits In Swiss Albino Mice
380. Nootropic Activity Of Albizzia Lebbeck In Mice
381. Nootropic Activity Of Bacomind, An Enriched Phytochemical Composition From Bacopa Monnieri
382. Nootropic Activity Of Butanolic Extract Passiflora Incarnata Leaves
383. Nootropic Activity Of Calyces Of Hibiscus Sabdariffa Linn
384. Nootropic Activity Of Caralluma Fimbriata Extract In Mice
385. Nootropic Activity Of Celastrus Paniculatus Seed
386. Nootropic Activity Of Crataeva Nurvala Buch-Ham Against Scopolamine Induced Cognitive Impairment
387. Nootropic Activity Of Ethanolic Extract Of Alangium Salvifolium Leaves On Scopolamine Mouse Model Of Alzheimer’S Disease
388. Nootropic Activity Of Extracts From Wild And Cultivated Alfredia Cernua
389. Nootropic Activity Of Glycinergic Derivatives In Relation To Their Dualistic Effects On Cerebral Monoamines
390. Nootropic Activity Of Lipid‐Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts
391. Nootropic Activity Of Lipid-Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts.
392. Nootropic Activity Of Moringa Oleifera Leaves
393. Nootropic Activity Of N-(2-Acetylaminoethyl) Glycolurils
394. Nootropic Activity Of Nicotinamide And Its Structural Analogs
395. Nootropic Activity Of Ocimum Gratissimum In Streptozotocin Induced Amnesia
396. Nootropic Activity Of Some Quinazoline Amides
397. Nootropic Activity Of Tuber Extract Of Pueraria Tuberosa (Roxb)
398. Nootropic Activity Of Ureidoacids And Thiohydantoins
399. Nootropic Activity Of Zingiber Officinale In Albino Mice: A Behavioral And Neurochemical Approach.
400. Nootropic Agent Vinpocetine Blocks Delayed Rectified Potassium Currents More Strongly Than High-Threshold Calcium Currents
401. Nootropic Agents Enhance The Recruitment Of Fast Gabaa Inhibition In Rat Neocortex
402. Nootropic Agents In The Complex Treatment Of Patients With Traumatic Epilepsy
403. Nootropic Agents Stimulate Neurogenesis: Brain Cells, Inc.: Wo2007104035
404. Nootropic And Adaptogenic Effect Of Combined Use Of Cortexin With Polyunsaturated Fatty Acids Concentrate Under Experimental Dislipidemia
405. Nootropic And Analgesic Effects Of Semax Following Different Routes Of Administration
406. Nootropic And Anti-Alzheimer’S Actions Of Medicinal Plants: Molecular Insight Into Therapeutic Potential To Alleviate Alzheimer’S Neuropathology
407. Nootropic And Anti-Amnestic Effect Of Ppa On Scopolamine-Induced Cognitive Impairment In Mice
408. Nootropic And Antiamnestic Effects Of Tenoten (Pediatric Formulation) In Immature Rat Pups
409. Nootropic And Antihypoxic Properties Of Novel Derivatives Of 1, 2-Dihydro-3H-1, 4-Benzodiazepin-2-One
410. Nootropic And Anti-Stress Effects Of Rice Bran Oil In Male Rats
411. Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
412. Nootropic And Anxiolytic Properties Of Endogenous Ligands Of Benzodiazepine Receptors And Their Structural Analogs
413. Nootropic And Hypophagic Effects Following Long Term Intake Of Almonds (Prunus Amygdalus) In Rats
414. Nootropic And Neuroprotective Effects Of Dichrocephala Integrifolia On Scopolamine Mouse Model Of Alzheimer’S Disease
415. Nootropic And Neuroprotective Effects Of Ethanol Extract Of Vateria Indica L Bark On Scopolamine-Induced Cognitive Deficit In Mice
416. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
417. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
418. Nootropic Candidates Inhibit Head-Twitches Induced By Mescaline In Mice
419. Nootropic Compound L-Pyroglutamyl-D-Alanine-Amide Restores Hippocampal Long-Term Potentiation Impaired By Exposure To Ethanol In Rats
420. Nootropic Correction Of Disturbances In Learning And Memory Caused By Superhigh Frequency Electromagnetic Radiation
421. Nootropic Dipeptide Noopept Enhances Inhibitory Synaptic Transmission In The Hippocampus
422. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
423. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
424. Nootropic Drug Evaluation For General Practice
425. Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors In Rat Cortical Neurons
426. Nootropic Drugs
427. Nootropic Drugs
428. Nootropic Drugs And Aging.
429. Nootropic Drugs And Brain Cholinergic Mechanisms
430. Nootropic Drugs And Their Action Mechanisms In Relation To The Neuropathobiology Of Senile Dementia. I. Neurotransmission Disorders In The Brain
431. Nootropic Drugs Glia Signalling Neurorobotics/Prosthetics Brain Imaging Technology Uses And Limitations/Fmri, Eeg Ect… Brain Training?
432. Nootropic Drugs Have Different Effects On Kindling-Induced Learning Deficits In Rats
433. Nootropic Drugs In Alzheimer Disease Treatment. New Pharmacological Strategies
434. Nootropic Drugs In Alzheimer’S Disease: Symptomatic Treatment With Pramiracetam
435. Nootropic Drugs Positively Modulate Α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid‐Sensitive Glutamate Receptors In Neuronal Cultures
436. Nootropic Drugs Potentiate Nerve Cell Responses Evoked By Nmda-Glutamate Receptor Activation
437. Nootropic Drugs Reduce Immobility In Behavioural Despair Test In Mice.
438. Nootropic Drugs: Animal Models For Studying Effects On Cognition
439. Nootropic Drugs: Evaluation On The Safety And Efficacy
440. Nootropic Drugs: Methylphenidate, Modafinil And Piracetam–Population Use Trends, Occurrence In The Environment, Ecotoxicity And Removal Methods–A Review
441. Nootropic Drugs: The Gap Between Preclinical And Clinical Results
442. Nootropic Effect Of Berberine In Colchicines Induced Experimental Alzheimer’S Disease Model: Effect On Cholinergic Neurotransmission
443. Nootropic Effect Of Br-16A (Mentat), A Psychotropic Herbal Formulation, On Cognitive Deficits Induced By Prenatal Undernutrition, Postnatal Environmental …
444. Nootropic Effect Of Combined Application Of Means From Baikal Seal Fat And Cortexin At Cerebral Ischemia
445. Nootropic Effect Of Complex Phytoremedy «Noophyt» Extract
446. Nootropic Effect Of Dangsheng, Codonopsis Pilosula (Franch.) Nannf [J]
447. Nootropic Effect Of Dengyin Nao Tong Capsule On Aging Mice
448. Nootropic Effect Of Ecuadorian Linseed Oil And Powder (Linum Usitatissimum) On Mus Musculus Mice
449. Nootropic Effect Of Forsythiaside On A Novel Complex Mouse Model Of Alzheimer Disease And Its Mechanism [J]
450. Nootropic Effect Of Ginsenoside Rg1 And Its Metabolites And Its Signaling Pathway
451. Nootropic Effect Of Meadowsweet (Filipendula Vulgaris) Extracts
452. Nootropic Effect Of Neferine On Aluminium Chloride–Induced Alzheimer’S Disease In Experimental Models
453. Nootropic Effect Of Nicotine On Carbon Monoxide (Co)-Induced Delayed Amnesia In Mice
454. Nootropic Effects Of Ace Inhibitors In Mice
455. Nootropic Effects Of Filipendula Vulgaris Moench Water Extract Fractions
456. Nootropic Effects Of New Drug Curdlipid C6
457. Nootropic Effects Of Synthetic Flavonoid Derivatives On Scopolamine Induced Memory Impairment In Mice Via Cholinesterase Inhibition And Antioxidant System.
458. Nootropic Efficacy Of Satvavajaya Chikitsa And Ayurvedic Drug Therapy: A Comparative Clinical Exposition
459. Nootropic Herbal Formulations For The Treatment Of Alzheimer’S Disease: In Vivo Pharmacological Assay And Molecular Docking Studies
460. Nootropic Herbs (Medhya Rasayana) In Ayurveda: An Update
461. Nootropic Medicinal Plants: Therapeutic Alternatives For Alzheimer’S Disease
462. Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
463. Nootropic Nanocomplex With Enhanced Blood-Brain Barrier Permeability For Treatment Of Traumatic Brain Injury-Associated Neurodegeneration
464. Nootropic Nefiracetam Inhibits Proconvulsant Action Of Peripheral‐Type Benzodiazepines In Epileptic Mutant El Mice
465. Nootropic Pharmacotherapy And Its Role In Solving The Problems Of Women Health
466. Nootropic Potential Of Alternanthera Sessilis And Clerodendrum Infortunatum Leaves On Mice
467. Nootropic Potential Of Ashwagandha Leaves: Beyond Traditional Root Extracts
468. Nootropic Potential Of Bauhinia Variegata: A Systematic Study On Murine Model
469. Nootropic Potential Of Murraya Koenigii Leaves In Rats
470. Nootropic Potential Of Silver Nanoparticles Of Boerhaavia Diffusa And Its Ethanolic Extract In High Fat Diet Model Of Dementia In Rats
471. Nootropic Preparations, The Achievements And New Problems
472. Nootropic Properties Of Gamma-Aminobutyric Acid Derivatives
473. Nootropic Signal Transduction Of Ginsenoside Rg1
474. Nootropic Studies Of Ethanolic Extract Of Mimosa Pudica Linn. In Albino Wistar Rats
475. Nootropic Substances Enhance The N-Methyl-D-Aspartate-Induced Short-Term Potentiation Of Synaptic Transmission In Rat Hippocampal Slices
476. Nootropic Supplements For Cognitive Improvement How To Prevent Alzheimer’S Disease
477. Nootropic Treatment And Combined Therapy In Age-Associated Memory Impairment
478. Nootropic Α7 Nicotinic Receptor Allosteric Modulator Derived From Gabaa Receptor Modulators
479. Nootropic , Anxiolytic And Cns-Depressant Studies On Different Plant Sources Of Shankhpushpi
480. Nootropic , Neuroprotective And Neurotrophic Effects Of Phloretin In Scopolamine Induced Amnesia In Mice
481. Normalization Of The Adaptive Avoidance Reaction In Rats Using Substances With Nootropic Activity
482. Novel Nootropic Dipeptide Noopept Increases Inhibitory Synaptic Transmission In Ca1 Pyramidal Cells
483. Novel Nootropic Drug Sunifiram Enhances Hippocampal Synaptic Efficacy Via Glycine‐Binding Site Of N‐Methyl‐D‐Aspartate Receptor
484. Novel Nootropic Drug Sunifiram Improves Cognitive Deficits Via Cam Kinase Ii And Protein Kinase C Activation In Olfactory Bulbectomized Mice
485. Novel Small Peptides With Neuroprotective And Nootropic Properties
486. Novel Validated Analytical Method Based On Potentiometric Transduction For The Determination Of Citicoline Psychostimulant/Nootropic Agent
487. On Some Mechanisms Of Antihypoxic Actions Of Nootropic Drugs.
488. Original Article Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
489. Original Nootropic Drug Noopept Prevents Memory Deficit In Rats With Muscarinic And Nicotinic Receptor Blockade
490. Outline For The Evaluation Of Nootropic Drugs
491. Over-The-Counter Stimulant, Depressant, And Nootropic Use By Veterinary Students
492. Over-The-Counter Stimulant, Depressant, And Nootropic Use In Veterinary Medical Students
493. Participation Of Dihydropyridine-Sensitive Calcium Channels In Psychotropic Effects Of Nootropic Drugs
494. Pass Assisted Prediction And Pharmacological Evaluation Of Novel Nicotinic Analogs For Nootropic Activity In Mice
495. Peculiarities Of Protein Metabolism At Administration To Prenatal Alcoholized Rats Of Aza-15-Crown-5 Ether Derivative With Nootropic Activity.
496. Peptide Analogs Of Pyracetam As Ligands For Hypothetical Nootropic Receptors
497. Peptidergic Nootropic Therapy In Cerebral Palsy Associated With Epilepsy
498. Performance Enhancement At The Cost Of Potential Brain Plasticity: Neural Ramifications Of Nootropic Drugs In The Healthy Developing Brain
499. Pharmacoeconomical Aspects Of Using Of Antianxious And Nootropic Preparations In Complex Treatment Of Patients With …
500. Pharmacokinetic And‐Dynamic Studies In Elderlies With A Potential Antihypoxidotic/Nootropic Drug Tenilsetam Utilizing Pharmaco‐Eeg And Psychometry
501. Pharmacokinetic Properties Of An Innovative Nootropic Agent Based On A Derivative Of 3, 7-Diazabicyclo [3.3. 1] Nonane
502. Pharmacokinetics And Brain Entry Of Alaptide, A Novel Nootropic Agent, In Mice, Rats And Rabbits
503. Pharmacokinetics Of A Nootropic Agent, Bmy-21502, And Its Metabolites In Beagle Dogs
504. Pharmacokinetics Of New Nootropic Acylprolyldipeptide And Its Penetration Across The Blood-Brain Barrier After Oral Administration
505. Pharmacokinetics Of The Potential Nootropic Drug Of-5858
506. Pharmacological Exploration Of Nootropic Activity Of Some Indigenous Medicinal Plants
507. Pharmacological Properties Of Digam—A New Potential Nootropic Drug
508. Pharmacological Validation Of In-Silico Guided Novel Nootropic Potential Of Achyranthes Aspera L.
509. Phenibut (Β‐Phenyl‐Gaba): A Tranquilizer And Nootropic Drug
510. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of
511. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger (Abelmoschus Esculentus L.) …
512. Phytochemical Screening And Invivo Nootropic Evaluation Of Carissacarandus Linn. Roots
513. Phytochemicals Analysis Of Formulated Ayurveda Rasayana Using Nootropic Herbs
514. Phytopharmacology Of Indian Nootropic Convolvulus Pluricaulis
515. Piperazines As Nootropic Agents: New Derivatives Of The Potent Cognition-Enhancer Dm235 Carrying Hydrophilic Substituents
516. Piracetam-Induced Changes In The Functional Activity Of Neurons As A Possible Mechanism For The Effects Of Nootropic Agents
517. Platelet Hyperreactivity And Antiaggregatory Properties Of Nootropic Drugs Under Conditions Of Alloxan-Induced Diabetes In Rats
518. Platelet-Activating Factor: A New Target Site For The Development Of Nootropic Agents
519. Possibilities Of Application Of Nootropic Drugs In Treatment Of Epilepsy (Literature Review)
520. Possibilities Of Correction For Vascular Cognitive Impairments Using Preparations With Combined Nootropic And Vasoactive Action
521. Possible Role Of Nitric Oxide In The Nootropic And Antiamnesic Effects Of Neurosteroids On Aging-And Dizocilpine-Induced Learning Impairment
522. Post‐Stroke Dementia: Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors
523. Potential Nootropic Agents, 4-Alkoxy-2-(1-Piperazinyl) Quinazoline Derivatives
524. Potential Nootropic Agents: Synthesis Of A Series Of (2-Oxo-1-Pyrrolidinyl) Acetic Acid Piperazides
525. Potential Nootropic Agents: Synthesis Of Some (2-Oxo-1-Pyrrolidinyl) Acetamides And Some Related Compounds
526. Potential Nootropic Agents: Synthesis Of Some 1, 4-Disubstituted 2-Oxopyrrolidines And Some Related Compounds
527. Potential Of Peptidergic Nootropic Therapy In Developmental Dysphasia In Children
528. Potentiation Of N-Methyl-D-Aspartate-Induced Currents By The Nootropic Drug Nefiracetam In Rat Cortical Neurons
529. Potentiation Of Nootropic Activity Of Egcg Loaded Nanosuspension By Piperine In Swiss Male Albino Mice
530. Potentiation Of Α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (Ampa)-Selective Glutamate Receptor Function By A Nootropic Drug, Idebenone
531. Practicable And Valid Approach To Evaluate The Efficacy Of Nootropic Drugs By Means Of Rating Scales
532. Preliminary Study On Nootropic Effect Of Vanda Tesselata Roots
533. Preparation And Screening Of Swarnaprashana For Nootropic Activity
534. Presynaptic Facilitation By The New Nootropic Drug Nebracetam, Of Ganglionic Muscarinic Transmission In The Dog Cardiac Sympathetic Ganglion.
535. Progress In The Study Of Nootropic Mechanisms Of Panax Ginseng
536. Progress On The Study Of The Effects Of Aging And Nootropic Drugs On Membrane Fluidity Of Neurons
537. Proline-Based Topologic Pyracetam Analogs And Their Nootropic Activity
538. Proline-Containing Dipeptide Gvs-111 Retains Nootropic Activity After Oral Administration
539. Prosopis Cineraria: A Potential Nootropic Agent
540. Prospective New Nootropic Substances Of The Group Of Amides Of P-Chlorophenoxyacetic And Propionic Acids
541. Protection From Phenytoin-Induced Cognitive Deficit By Bacopa Monniera, A Reputed Indian Nootropic Plant
542. Protection Of Cell Proteins Against Free-Radical Attack By Nootropic Drugs: Scavenger Effect Of Pyritinol Confirmed By Electron Spin Resonance Spectroscopy
543. Psychopharmacological Properties Of Peptides With Nootropic Type Of Action
544. Psychophysiological Research In Psychiatry And Neuropsychopharmacology. Ii. The Investigation Of Antihypoxidotic/Nootropic Drugs (Tenilsetam And Co-Dergocrine …
545. Psychotropic Properties Of Nootropic Substances With A Cholinergic Action Component In Single And Long-Term Use
546. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
547. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
548. Quantitative Evaluation Of The Anxiolytic And Nootropic Effects Of Potassium Orotate In A Wide Range Of Doses
549. Radioelectroencephalographic Characterization Of Tenilsetam (Cas 997), A Putative Nootropic Compound, In The Freely Behaving Rat
550. Rapid Inhibition Of Exploratory Movements As A Test Of Nootropic Activity
551. Regeneration Potential And Major Metabolite Analysis In Nootropic Plant-Bacopa Monnieri (L.) Pennell
552. Regulatory System Of Brain Chromatin In Nootropic Action
553. Repurposing Of The Nootropic Drug Vinpocetine As An Analgesic And Anti-Inflammatory Agent: Evidence In A Mouse Model Of Superoxide Anion-Triggered …
554. Research Article Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger …
555. Results Of Treatment With A Broad-Acting Nootropic Preparation On Chronic Diffuse Cerebral Disturbances
556. Retracted:Nootropic ‐Like Effect Of Ashwagandha (Withania Somnifera L.) In Mice
557. Reversal Of Scopolamine-Induced Amnesia And Alterations In Energy Metabolism By The Nootropic Piracetam: Implications Regarding Identification Of Brain Structures …
558. Role Of Functional State Of Neuronal Mitochondria Of Cerebral Cortex In Mechanisms Of Nootropic Activity Of Neuroprotectors In Rats With Alloxan Hyperglycemia
559. Role Of Medhya Rasayana (Nootropic Herbs) In Present Scenario: An Ayurvedic Overview
560. Role Of Metabotropic Glutamate Receptor Subclasses In Modulation Of Adenylyl Cyclase Activity By A Nootropic Ns-105
561. S‐52, A Novel Nootropic Compound, Protects Against Β‐Amyloid Induced Neuronal Injury By Attenuating Mitochondrial Dysfunction
562. Safety And Tolerability Of The Anxiolytic And Nootropic Drug Phenibut: A Systematic Review Of Clinical Trials And Case Reports
563. Scopolamine-Induced Amnesia Model: A Possible Anticholinergic Mechanism With Reversibility With Statins And Nootropic Agents
564. Screening And Personalizing Nootropic Drugs And Cognitive Modulator Regimens In Silico
565. Screening Of Aqueous And Ethanolic Extracts Of Aerial Parts Of Alternanthera Sessilis Linn. R. Br. Ex. Dc For Nootropic Activity
566. Screening Of Black Spruce Oilfor Nootropic Activity In Rats
567. Screening Of Taxillus Tomentosus Ethanolic Extract For Nootropic And Antistress Activity In Rats
568. Search For A Perfect Nootropic Supplement Combination-Can We Increase Human Intelligence By Nutritional Supplements
569. Search For Nootropic Substances Based On Molecular Docking Of Methanepyrido[1,2-A][1, 5]Diazocin[(-)-Cytisine] Derivatives To The Active Center Of The Nicotinic …
570. Semax, An Acth (4-10) Analogue With Nootropic Properties, Activates Dopaminergic And Serotoninergic Brain Systems In Rodents
571. Senile Dementia Of The Alzheimer Type Treated With Aniracetam: A New Nootropic Agent
572. Shortening Of N1 And P3 Latencies In Event‐Related Potentials Observed Coincidentally With Clinical Improvement During Nootropic Medication In A Demented …
573. Single‐And Multiple‐Dose Pharmacokinetics Of Nefiracetam, A New Nootropic Agent, In Healthy Volunteers
574. Solid-State Structure And Conformation Of The Nootropic Agent 4-Hydroxy-2-Oxo-1-Pyrrolidineacetamide: X-Ray And Theoretical Self-Consistant Field Molecular Orbital (Scf …
575. Solid-State Structure And Solution Conformation Of The Nootropic Agent N [2-(N, N-Diisopropylamino) Ethyl]-2-Oxo-1-Pyrrolidinacetamide Sulphate. X-Ray And …
576. Some Clinical Studies With Piracetam–A “Nootropic ” Substance
577. Some Considerations Of Different Modes Of Action Of Nootropic Drugs
578. Space-Oriented Eeg Segmentation Reveals Changes In Brain Electric Field Maps Under The Influence Of A Nootropic Drug
579. Specific Modulation Of Social Memory In Rats By Cholinomimetic And Nootropic Drugs, By Benzodiazepine Inverse Agonists, But Not By Psychostimulants
580. Spect Monitoring Of Improved Cerebral Blood Flow During Long-Term Treatment Of Elderly Patients With Nootropic Drugs
581. Spectral And Frequency Analysis Of The Central Eeg Activity In Parkinson’S Disease Patients With Alzheimer’S Disease: The Development During Nootropic Therapy
582. Spiro-[4H-Pyrroio[1,2-A][1,4]Benzodiazepine-4,4′-Piperidine] Derivatives As Potential Nootropic Agents: A Simple One-Pot Synthesis
583. Steady State Visually Evoked Potential (Ssvep) Phase Change As An Index Of Spatial Working Memory Task Performance: The Influence Of Nootropic Supplementation
584. Structure Of Acetylcholinesterase Complexed With The Nootropic Alkaloid,(–)-Huperzine A
585. Studies Of The Lipophilic Components Of A Dense Extract Of The Herb Alfredia Cernua And Its Nootropic Properties
586. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-# Beta#-D-Glucopyranoside
587. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-?-D-Glucopyranoside
588. Studies On Nootropic Activity Of Roots Of Tylophora Indica In Mice
589. Studies On Nootropic Effects Of Various Extracts Of Gmelina Arborea And Cayratia Trifolia
590. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg_1 And Its Mechanisms Of Actions [J]
591. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg1 And Its Mechanisms Of Actions
592. Studies On The Metabolism And The Toxicological Analysis Of The Nootropic Drug Fipexide In Rat Urine Using Gas Chromatography–Mass Spectrometry
593. Studies On The Nootropic And Anti-Amnestic And Anxiolytic-Like Effects Of Gjd-Ppa In Mice
594. Study Of The Effects Of Nootropic Agents On The Adrenergic Neurotransmission In Smooth Muscles Of Young And Old Animals.
595. Study Of The Protective Effects Of Nootropic Agents Against Neuronal Damage Induced By Amyloid-Beta (Fragment 25–35) In Cultured Hippocampal Neurons
596. Study On Nootropic Activity Of Aegle Marmelos L Fruits
597. Study On Nootropic Activity Of Root Extracts Of Adhatoda Vasica Nees In Mice And Rats
598. Study On The Nootropic Mechanism Of (-) Clausenamide-Influence On The Formation Of Synapses In Mouse Brain
599. Study On The Nootropic Mechanism Of Ginsenoside Rb1 And Rg1–Influence On Mouse Brain Development
600. Study On The Nootropic Mechanism Of Ginsenosides
601. Studying Specific Effects Of Nootropic Drugs On Glutamate Receptors In The Rat Brain
602. Studying The Nootropic Effects Of Betamecil
603. Substituted Piperazines As Nootropic Agents: 2-Or 3-Phenyl Derivatives Structurally Related To The Cognition-Enhancer Dm235
604. Synchronization In The Functioning Of Neurons Of The New Cortex And Hippocampus During Learning Before And After The Administration Of Nootropic Agents And Narcotics
605. Synthesis And Biological Evaluation Of 3, 7-Diazabicyclo [4.3. 0] Nonan-8-Ones As Potential Nootropic And Analgesic Drugs
606. Synthesis And Biological Evaluation Of Schiff’S Bases And 2-Azetidinones Of Isonocotinyl Hydrazone As Potential Antidepressant And Nootropic Agents
607. Synthesis And Inhibitory Activity Of Acylpeptidyl-Prolinal Derivatives Toward Post-Proline Cleaving Enzyme As Nootropic Agents
608. Synthesis And Nootropic Acitivity Of N-Acyl-4-Phenyel-2-Pyrrolidones
609. Synthesis And Nootropic Activity Of 2-Oxo-1-Pyrrolidinesulfonic Acid Derivatives.
610. Synthesis And Nootropic Activity Of New 3-Amino-12-N-Methylcytisine Derivatives
611. Synthesis And Nootropic Activity Of Oxamoylamino Acids
612. Synthesis And Nootropic Activity Of Pyrrolidino [1, 2-A] Diazacycloalkanes
613. Synthesis And Nootropic Activity Of Some 2,3‐Dihydro‐1H‐Isoindol‐1‐One Derivatives Structurally Related With Piracetam
614. Synthesis And Specific Nootropic Activity Of (–)-Cytisine Derivatives With Carbamide And Thiocarbamide Moieties In Their Structure
615. Synthesis Of 4-Phenylpyrrolidone Derivatives With Anticonvulsant And Nootropic Activity
616. Synthesis Of The 3-Hydroxy Oxiracetam Enantiomers, Potential Nootropic Drugs
617. Synthesis Of The Benzenoid Analogue Of The Chinese Nootropic Agent Huperzine A
618. Synthesis Of The Nootropic Drug S-Stereoisomer Of Oxiracetam
619. Synthetic Acth Analogue Semax Displays Nootropic ‐Like Activity In Humans
620. The “Nootropic ” Approach To The Pharmacology Of The Integrative Activity Of The Brain 1, 2
621. The Acute Nootropic Effects Of Ginkgo Biloba In Healthy Older Human Subjects: A Preliminary Investigation
622. The Antiamnestic Effect Of Nootropic Substances In Rats
623. The Antihypoxic Effect Of Ethymisole: A Comparison With Other Nootropic Drugs.
624. The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than Classical Cocaine-Like Inhibitors
625. The Bioavailability Of Tableted Drug Forms Of The New Russian Nootropic Preparation Nooglutil In Rabbits
626. The Brain Functions By Bitter (Vernonia Amygdalina) And Water Bitter (Struchium Sparganophora) Leaves Extracts: Comparison Of Phenolic Constituents Versus Nootropic …
627. The Conjuncture Analysis Of The Range Of Nootropic Drugs Registered In Ukraine
628. The Development Of The Physicochemical Characteristics Of The New Original Nootropic Substance Tst-9
629. The Dose-Dependency Of The Effects Of 2 Methyl 3 (Phenylaminomethyl)-1H-Quinolin-4 One–A Promising Antidepressant With Nootropic Properties
630. The Eaa-Ergic Modulation Of The Brain Dopaminergic System As A Basis For Creating New Nootropic Agents With Stress-Protective Activity
631. The Effect Of Combined Therapy Of Exercise And Nootropic Agent On Cognitive Function In Focal Cerebral Infarction Rat Model
632. The Effect Of Enzyme Induction And Inhibition On The Disposition Of The Xanthine-Related Nootropic Drug Ethimizol In Perfused Liver And Hepatocytes Of Rats.
633. The Effect Of Nootropic Agents On Brain Mitochondrial Function In The Dynamics Of Craniocerebral Trauma From The Age Aspect
634. The Effect Of Nootropic Agents On The Biochemical Parameters Of The Blood Serum From Children With Intellectual Deficit.
635. The Effect Of Preparations With Nootropic Action When Used Long-Term On The Brain Bioelectrical Activity In Rats
636. The Effect Of Substances With Nootropic Activity On Oxidative Phosphorylation In Brain Mitochondria In Acute Craniocerebral Trauma
637. The Effect Of The New Nootropic Dipeptide Gvs-111 In Different Functional Disorders Of The Escape Reaction
638. The Effects Of Anti-Dementia And Nootropic Treatments On The Mortality Of Patients With Dementia: A Population-Based Cohort Study In Taiwan
639. The Effects Of Nootropic Drugs On Metabotropic Glutamate Receptors In The Brains Of Balb/C And C57Bl/6 Mice
640. The Effects Of Scopolamine And The Nootropic Drug Phenotropil On Rat Brain Neurotransmitter Receptors During Testing Of The Conditioned Passive Avoidance Task
641. The Establishment Of Computer-Based Auto-Controlling And Image-Analysing Processing System Of Circle Water-Maze For Studying Nootropic Drugs From Traditonal …
642. The Fluorescence And Resonance Rayleigh Scattering Spectra Study On The Interactions Of Palladium (Ii)-Nootropic Chelate With Congo Red And Their Analytical …
643. The Functional Importance Of Cerebral Noradrenergic Processes For The Activating Action Of Nootropic Drugs In The Behavioural Despair Test In Mice.
644. The Gabab Receptor Antagonist Cgp 36 742 And The Nootropic Oxiracetam Facilitate The Formation Of Long-Term Memory
645. The Influence Of Piracetam On Behavior And Brain Receptors In C57Bl/6 And Balb/C Mice: Nootropic And Anxiolytic Effects
646. The Influence Of The Semax Nootropic Agent On The Behavioral Signs Of The Withdrawal Syndrome And On The Craving For Alcohol In White Rats And The Determination Of Its …
647. The Interaction Of Nootropic Drugs With Anticonvulsants.
648. The New Nootropic Mechanism Of Action Of The Modern Antidepressant Rolipram On Cognitive Functions
649. The Nootropic Agent Vinpocetine Blocks The Delayed Rectifier Potassium Channel More Strongly Than The High-Conductance Calcium Channel
650. The Nootropic And Analgesic Effects Of Semax Given Via Different Routes
651. The Nootropic And Anticholinesterase Activities Of Clitoria Ternatea Linn. Root Extract: Potential Treatment For Cognitive Decline
652. The Nootropic And Anxiolytic Properties Of Different Doses Of Piracetam
653. The Nootropic And Neuroprotective Proline-Containing Dipeptide Noopept Restores Spatial Memory And Increases Immunoreactivity To Amyloid In An Alzheimer’S Disease …
654. The Nootropic Components Of Hovenia Dulcis.
655. The Nootropic Compound Bmy-21502 Improves Spatial Learning Ability In Brain Injured Rats
656. The Nootropic Concept And Dyslexia
657. The Nootropic Concept And Its Prospective Implications
658. The Nootropic Correction Of Disorders In Learning And Memory Processes Induced By Extreme Exposures
659. The Nootropic Drug Vinpocetine Inhibits Veratridine-Induced [Ca2+] I Increase In Rat Hippocampal Ca1 Pyramidal Cells
660. The Nootropic Drug Vinpocetine Modulates Different Types Of Potassium Currents In Molluscan Neurons
661. The Nootropic Drug Α-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects In Human Hippocampal Cells
662. The Nootropic Drugs Piracetam And Oxiracetam Do Not Reduce Anxiety In Mice During Elevated-X-Maze Testing
663. The Nootropic Properties Of Ginseng Saponin Rb1 Are Linked To Effects On Anxiety
664. The Nootropic Properties Of The Tetrapeptide Acetyl-(D-Lys)-Lys-Arg-Arg-Amide (Kk-1) On The Model Of Scopolamine-Induced Alzheimer’S Disease In Rats
665. The Novel Dipeptide Translocator Protein Ligand, Referred To As Gd-23, Exerts Anxiolytic And Nootropic Activities
666. The Novel Nootropic Compound Dm232 (Unifiram) Ameliorates Memory Impairment In Mice And Rats
667. The Original Nootropic And Neuroprotective Drug Noopept Potentiates The Anticonvulsant Activity Of Valproate In Mice
668. The Original Novel Nootropic And Neuroprotective Agent Noopept
669. The Pharmacokinetic Characteristics Of The New Psychotropic Preparation With Nootropic Action Onk-10 In The Progeny Of Alcoholized Animals
670. The Pharmacokinetics Of The Dipeptide Analog Of Piracetam With Nootropic Activity Gvs-111 And Of Its Basic Metabolites
671. The Pharmacology Of Nootropic Drugs: Geropsychiatric Implications
672. The Placebo Effect Of A Nootropic And Verbal Placebo In Enhancing The Cognitive Ability Of Children Focusing On Memory Recall.
673. The Problem Of Nootropic Pharmacotherapy Safety In Neurological Practice
674. The Research Progress Of A Single Traditional Chinese Medicine’S Mechanism About Nootropic Effect [J]
675. The Significance Of The Antihypoxic Properties Of Etimizol In Its Nootropic Action
676. The Synthesis Of (4-Sup 3 H) Oxiracetam-A Novel Nootropic Agent
677. The Synthesis Of [4‐3H]Oxiracetam ‐ A Novel Nootropic Agent
678. The Treatment With Antihypertensive And Nootropic Preparations Of Hypertension Patients Working Under Neuroemotional Stress
679. The Use Of A Scopolamine Model To Study The Nootropic Effects Of Tenilsetam (Cas 997) In Man.
680. The Use Of A Scopolamine Model To Study The Potential Nootropic Effects Of Aniracetam And Piracetam In Healthy Volunteers
681. The Use Of The Hplc Method For The Quantitative Determination Of A Peptide Analog Of Piracetam With Nootropic Activity And Its Main Metabolites
682. The Use Of Xenopus Oocytes To Evaluate Drugs Affecting Brain Ca2+ Channels: Effects Of Bifemelane And Several Nootropic Agents
683. The Usefulness Of Event-Related Negativity In Demonstrating The Therapeutic Effects Of Nootropic Drugs Using Cerebrolysin As An Example
684. Therapeutic Efficacy Of Nootropic Drugs In Alzheimer’S Disease And Age Related Cognitive Dysfunction
685. Therapeutic Efficacy Of Nootropic Drugs—A Discussion Of Clinical Phase Iii Studies With Nimodipine As A Model
686. Three-Dimensional Pharmacophoric Pattern Search Using Compass: Nootropic Agents
687. Traditional Chinese Nootropic Medicine Radix Polygalae And Its Active Constituent Onjisaponin B Reduce Β-Amyloid Production And Improve Cognitive …
688. Treatment Of Experimental Destruction Of The Duodenum With Preparations With Nootropic Action
689. Treatment Of Raynaud Syndromes With Piracetam (Nootropil R), Nootropic And Aniplatelet Agent
690. Treatment With Nootropic Drugs
691. Trophic Effects Of Nootropic Peptide Preparations Cerebrolysin And Semax On Cultured Rat Pheochromocytoma
692. Ucb 11056, A New Potential Nootropic Drug, Amplifies Induced Cyclic Amp Formation In Rat Brain Tissue
693. Varsity Medical Ethics Debate 2015: Should Nootropic Drugs Be Available Under Prescription On The Nhs?
694. Vinpocetine: Nootropic Effects On Scopolamine-Induced And Hypoxia-Induced Retrieval Deficits Of A Step-Through Passive Avoidance Response In Rats
695. X-Ray And 1H-Nmr Spectroscopic Studies Of The Structures And Conformations Of The New Nootropic Agents Ru-35929, Ru-47010 And Ru-35965
696. X-Ray, Nmr And Theoretical Studies Of The Structure And Conformation Of The Nootropic Agent Tenilsetam
697. X‐Ray, Nmr, And Theoretical Studies Of The Nootropic Agent Bmy‐21502, A Pyrrolidinone Derivative
698. Zingiber Officinale: Evaulation Of Its Nootropic Effect In Mice